申请人:Roche Diagnostics Operations, Inc.
公开号:US11415576B2
公开(公告)日:2022-08-16
The present invention concerns an in vitro method for measurement of 25-hydroxyvitamin D, wherein the potentially interfering compound 24,25-dihydroxyvitamin D3 is blocked by a binding agent specifically binding to 24,25-dihydroxyvitamin D3 and not binding to 25-hydroxyvitamin D.
本发明涉及一种测量 25-羟基维生素 D 的体外方法,其中潜在干扰化合物 24,25-二羟基维生素 D3 被一种专门与 24,25-二羟基维生素 D3 结合而不与 25-羟基维生素 D 结合的结合剂阻断。